Product information
Price | €175, €275, €395 |
---|---|
Size | 20 µl/µg | 50 µl/µg | 100 µl/µg |
Short name | ERGIC-3 Antibody |
Host | Rabbit |
Isotype | IgG |
Target protein | ERGIC3 |
Recommended applications | ELISA, IF, IHC-p, WB |
Reactivity | Human, Mouse |
Immunogen | The antiserum was produced against synthesized peptide derived from human ERGI3. AA range:321-370 |
Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Formulation | Liquid in PBS containing 50% glycerol; 0.5% BSA and 0.02% sodium azide. |
Storage | -20°C for 1 year |
Product code | MB-AP10708 |
Additional information
Prev
Next
The ERGIC3 protein was also over-expressed in lung cancer tissues and cultured cells, and expression of ERGIC3 was correlated with the differentiated degree and histological type of lung cancer (PMID: 23374247). The up-regulation of ERGIC3 could promote cellular migration and proliferation in vitro. ERGIC3 may play an active role in the development and progression of lung cancer (PMID: 23374247). The MW of this protein is 50 kDa, and this antibody specially recognises the 50 kDa protein.
ERGIC3, C20orf47, ERV46, SDBCAG84, CGI-54, Endoplasmic reticulum-Golgi intermediate compartment protein 3, Serologically defined breast cancer antigen NY-BR-84
Human: Q9Y282, Mouse: Q9CQE7
Human: 51614, Mouse: 66366